Our Formulation Support Includes
We develop advanced liposomal formulations with the right phospholipid selection, high encapsulation efficiency, controlled particle size, stable zeta potential, improved bioavailability, and targeted delivery. Our unique solvent-free green manufacturing system combines multiple specialised process technologies, ensuring superior product stability, stronger process control, and global regulatory compliance.
End-to-End Development Support
-
Excipient Optimisation for Formulation Performance and Robustness
- Engineering functional matrices to optimize process compatibility, active stability, and targeted delivery mechanics.
- Formulating advanced polymeric architectures to optimize structural stability, active bio accessibility, and manufacturing compatibility.
-
Advanced Engineering for Superior Formulation Performance
- Optimisation of encapsulation efficiency, particle size distribution, zeta potential, release kinetics, stability profile for superior performance.
- Optimizing structural matrices to enhance geometric compatibility, active stabilization, and advanced delivery efficiency.
-
Prototype development feasibility
Scientific laboratory-scale development with technical evaluation, process validation, compatibility studies, and performance benchmarking, establishing viability.
Segment-Specific Formulation Approach
-
Oral Solid Formulation System
An automated, cGMP-compliant platform engineered for the precise blending, granulation, and compression of active pharmaceutical ingredients into tablets or capsules.
-
Sublingual and buccal systems
Specialised mouth sprays (B12, D3, melatonin) offer direct bloodstream access, bypassing first-pass hepatic metabolism.
-
Enteric-coated delivery
Precise coating optimisation ensuring 100% stomach protection with complete intestinal release within minutes.
-
Effervescent dynamics
Calcium effervescent tablets optimised for a clear solution without residue, providing a premium consumer experience.
-
Topical penetration systems
Franz diffusion cell-validated formulations demonstrating superior deep-tissue penetration compared to standard topical applications.
Specialised Format Engineering
-
Film-coated tablet stability
Integration of liposomal concentrates into solid dosage, maintaining vesicle integrity through compression and coating processes.
-
Chewable and dissolving tablets
Rapid salivary release optimisation with taste-masking technology eliminating metallic mineral tastes.
-
Liquid suspension mastery
Zeta potential optimisation, preventing sedimentation while maintaining colloidal stability throughout shelf-life.
-
Spray pattern optimisation
Precise droplet size and plume geo
Process & Manufacturing
- Critical parameter optimisation
Systematic optimisation of Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) to achieve process robustness and reproducibility. - Scale-up manufacturing readiness
Seamless transition from laboratory to commercial-scale production through validated strategies, process standardisation, and GMP-compliant preparedness. - Stability study validation
Comprehensive accelerated and real-time evaluation establishing shelf-life, physicochemical integrity, and packaging compatibility under defined storage conditions - Quality Control & Batch Reproducibility
Stringent in-process controls, analytical verification, and process standardisation ensuring batch-to-batch consistency, specification compliance, and manufacturing reliability.
High-Performance Architecture
-
Bottom-up vesicle formation
Engineering complex, stable molecular architectures through deep understanding of lipid biophysics, ensuring active sequestration within bilayers.
-
Advanced Engineering and Bioavailability Enhancement
- Engineering delivery systems ensuring >95% active penetration into epidermis/dermis while restricting surface residency to <5%.
- Synthesizing advanced macromolecular architectures to maximize encapsulation efficiency, guarantee molecular payload stabilization, and modulate targeted site-specific delivery kinetics.
-
Particle Engineering & Bioavailability Enhancement
Modulating crystalline morphology and particle size metrics to maximize saturation solubility, dissolution kinetics, and systemic bioavailability.
-
Multi-Layer Protection Technology
Engineered multi-lamellar polymeric coatings sequentially mitigate chemical degradation, prevent premature degradation, and modulate site-specific, stimuli-responsive payload release profiles.
-
Controlled Release Architecture
Utilizes sequential, synergistic barriers—such as polymeric encapsulation and antioxidant co-matrices—to prevent core degradation and optimize targeted delivery.
Specialised Technical Solutions
-
Acid complex stabilisation
Mastery of glycolic acid and salicylic acid inclusion within liposomal systems utilising specific buffering and stabilisers.
-
Hair growth innovation
Specialised formulation for targeted hair-nutrient actives using unique solubilisation techniques, overcoming crystallisation and precipitation.
-
Colour protection protocols
Stabilisation of L-glutathione, ethyl ascorbic acid, alpha lipoic acid using specialised preservation and intrinsic lipid-phase stabilisers.
-
Solvent-free system development
Achieving transparency through mechanical particle reduction and strategic humectant use rather than harsh solvents.
Risk & Error Assessment
-
Strategic QbD Implementation
Failure Mode and Effects Analysis (FMEA), risk prioritisation matrices, multivariable process mapping, and establishing proactive control.
-
Process control validation
Real-time monitoring protocols, statistical process control implementation, ensuring consistent batch-to-batch quality and manufacturing excellence.
-
Corrective action verification
Scientific validation of implemented solutions through analytical testing, stability assessment confirming restored formulation robustness.
-
Comprehensive failure evaluation
Advanced root cause analysis (RCA), failure mode assessment, CQA investigation identifying instability, low encapsulation, and phase inversion.
-
Process rectification optimisation
Strategic correction of critical deficiencies through excipient compatibility optimisation, lipid-to-active ratio, and homogenisation kinetics improvement.
-
Scientific deviation assessment
Analysis of oxidative degradation, leakage, particle agglomeration, sedimentation, and compromised bioavailability, delivering validated corrective actions.
Formulation Challenges We Resolve
Comprehensive control of lipid peroxidation, hydrolytic degradation, phase inversion, precipitation, and vesicle leakage through advanced stabilisation.
Precision improvement of low efficiency, inadequate loading, incomplete entrapment through lipid-to-active ratio balancing and vesicle engineering.
Strategic removal of batch-to-batch inconsistency, spray drying variations, coating non-uniformity through CPP optimisation and analytical control.
Advanced Technical Troubleshooting
Membrane integrity loss, active release, vesicle rupture corrected through stabiliser optimisation
Low loading, incomplete entrapment, poor retention resolved through ratio balancing and process refinement
Clumping, sedimentation, and size growth was prevented through zeta potential calibration and dispersant selection.
Taste masking failures, texture issues, colour changes addressed through barrier technologyand flavouringg systems
Process variability, equipment limitations, and yield inconsistencies are overcome through systematic parameter optimisation.
Formulation Development & Optimization Readiness
Selection Of Appropriate Liposomal Architecture (Unilamellar, Multilamellar, Nanoliposomes) Based On Active Characteristics, Target Delivery Site, And Commercial Requirements.
Scientific Laboratory-scale Development With Technical Feasibility Evaluation, Compatibility Assessment, Performance Benchmarking, Establishing Formulation Viability And Commercial Potential.
Systematic Optimisation Of Manufacturing Parameters, Equipment Selection, And Quality Control Implementation, Ensuring Reproducible Commercial Production And Regulatory Compliance.
Comprehensive accelerated and real-time stability studies establishing shelf-life specifications, packaging requirements, storage conditions supporting regulatory submissions and market launch.
Why Partner with Lipoedge for Formulation Support
Optimizes encapsulation efficiency, particle size distribution, zeta potential, and release kinetics for superior performance.
Systematically optimizes Critical Process Parameters (CPPs) and Critical Quality Attributes (CQAs) for reproducible, large-scale production.
Leverages lipid biophysics for bottom-up vesicle formation, achieving sub-100nm particle ranges through proprietary mechanical processing.
Engineers advanced delivery systems ensuring over 95% epidermal/dermal penetration while strictly limiting surface residency.
Employs root cause analysis and multivariable process mapping to correct oxidative degradation, leakage, and agglomeration.
Provisions automated, cGMP-compliant platforms across sublingual, enteric-coated, effervescent, and Franz diffusion cell-validated topical applications.
Clarity achieved through precise mechanical processing using high-speed homogenization and probe sonication. This reaches sub-100nm particle ranges, ensuring vesicles avoid light scattering while maintaining potency.
Calibration to a stable zeta potential (typically >±30 mV) maintains a strong electrostatic charge between vesicles. This prevents aggregation, which can cause cloudiness or precipitation over extended storage periods.
Transparency is achieved through mechanical particle reduction and strategic use of humectants rather than ethanol. This provides clarity without drying effects associated with high solvent concentrations.
Our benchmark ensures over 95% of actives penetrate epidermis and dermis for targeted action. We restrict surface residue to less than 5% through engineered partitioning technology.
We utilise specific buffering systems and proprietary stabilisers to protect liposomal structural integrity. This prevents leaking or aggregation, which typically occurs due to pH stress in standard formulations.
High-speed centrifugation simulates intense long-term physical stress testing. Zero-phase separation confirms the structural integrity of the phospholipid bilayer and guarantees active encapsulation throughout shelf-life.